| abstract |
The present invention is a polyvalent, preferably divalent, antibody complex capable of recognizing and binding the human protein CD99, more preferably a diabody, that is, a divalent scFv, a composition comprising the complex and leukemia and/or myelodysplastic syndrome And/or its use for diagnostic purposes and/or treatment and/or subsequent treatment. In addition, the present invention is an antibody capable of recognizing and binding human protein CD99, preferably an immunoglobulin G group type monoclonal antibody, a composition comprising the immunoglobulin, and, in particular, cancer, preferably expressing CD99. It relates to a pharmaceutical use thereof, for use in the treatment and/or subsequent treatment of solid tumors and/or leukemia and/or myelodysplastic syndrome. |